Suez Canal Blockage Could Cost Lloyd’s Nearly ‘$100 Million Or More’
Lloyd’s also informed that there was “10.8%” rise in premium rates last year, while the upward rising momentum of the graph continues even in 2021.
Lloyd’s also informed that there was “10.8%” rise in premium rates last year, while the upward rising momentum of the graph continues even in 2021.
In comparison, analysts at Refinitiv had estimated an average of “$3.03 billion for 2021 and about $2.6 billion for the latest quarter”.
Johnson & Johnson’s 2021 profit forecast goes way higher than “Wall Street estimates”.
The “UK Medicines and Healthcare products Regulatory Agency” gave its approval for Oxford/AstraZenca vaccine whereby vindicating the step towards essential “mass immunisations” across the globe.
A health worker in California tested positive for COVID-19 following a week of vaccination.
Holiday weekend could also result in increased market volatility.
Has the winning year for ‘corporate stay-at-homes’ come to an end?
Recovered oil prices and cost reduction have resulted in surprise Q3 profits.
Pfizer is expecting to get its “manufacturing data ready” for submitting to the regulators by late November.
British Health Secretary does not rule out the possibility of the vaccine reaching some people in 2020 itself.
The Health Ministry of Singapore reported that its has been over two months that no death has occurred in the island country due to COVID-19 infection.
Andy Bird will be replacing current CEO, John Fallon, and will assume the role from October 19, 2020.
In a provisional “potential” loss in loans across these banks could go up to “$22 billion” whereby leaving the previous “analyst forecasts” behind and ramping up pressure on selling shares which already took a beating due to the ongoing global pandemic.
Through simple steps, ensuring safety, government in Ontario have allowed people to be part of one social circle.
Doctors in Italy find “the COVID-19 disease is different” at present.
General Motors planned on a “seven business days” operation model to cope with shrinking exports.
Failure to arrive at a COVID-19 treatment could prove a bit global economic “tripping point”.
Despite the uncertainty, the small and medium sized U.S. corporate sector seem to show “surprising resiliency”.
Chris Tyas joins DEFRA as its Food Supply’s Director to contain situation over food security as the COVID-19 pandemic deepens.